Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

This step is important to make sure that only the best and safest treatments are tested on humans in clinical trials. The team examined postmortem brain tissues from Alzheimer's patients using ...

A new study finds that dementia cases will increase at a much higher rate than expected, with lifetime risk rising to 42 ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

Kathy Ingebrand was diagnosed with Alzheimer's at 59 years old. "This patient is receiving a treatment, which is designed to clear a protein called amyloid from the brain, which is accumulating in ...

Advisory group guidance enables nonprofit to be at the forefront of Alzheimer's research WELLESLEY HILLS, MA / ACCESSWIRE / ...

Eli Lilly ( LLY 1.80%) and Novo Nordisk ( NVO 2.76%) are two of the most valuable healthcare stocks in the world, largely due ...

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment ... based on current information and ...

characterised by cognitive impairment and memory loss. Professor Götz said current medications target disease progression and symptoms but don't offer patients a cure. "Therapeutic ultrasound ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...

While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...

Open to all Mississippi residents, the conference will feature expert-led sessions on Alzheimer’s disease, caregiving ...